glp 1 grey Pfizer's win signals what's to come in obesity drug M&A The GLP-1 Landscape: Commercial And
Description
Nausea, vomiting, diarrhea, and abdominal pain are some of the more common side effects of weight-loss medications (for a full list of side effects, visit the drug manufacturers website)
The stakes are higher than most realize
Each company filed continuation patents, pursued new indications, and built defensive walls around their core molecules
Poor response to GLP-1 therapy with continued weight loss and hyperglycaemia may occasionally indicate misdiagnosed diabetes type
Alcohol is a stomach irritant
